Skip to main content
All Posts By

Laura McWhinney

Clinical Trials

Predictive Power of Perceived Leadership

The Industry Standard Research CRO Benchmarking reports contain service provider experiences and perspectives from recent users in the biopharmaceutical sphere. This information can inform sponsor organizations to make more educated CRO selections for their Phase I, II, and III studies.…

How Industry Benchmarks Can Inform CDMO Selection

Biopharmaceutical sponsor considerations when selecting a CDMO may include timelines, cost, regulatory requirements, capacity, quality, risks, and previous experience. To help sponsors better understand and prioritize development and manufacturing elements, ISR conducts four annual, manufacturing-specific benchmark studies that ask professionals…

Decentralized Clinical Trials: Evolving Post-Pandemic

Decentralized clinical trials (DCTs) are studies in which some or all trial-related activities are conducted at a location separate from the investigators’ primary site. DCTs’ numerous benefits include convenience and flexibility for patients, greater opportunities for patient recruitment, increased patient…